The number of women who've been handed a bipolar or depression diagnosis in their forties — only to discover years later that their oestrogen was cratering — is genuinely heartbreaking. It doesn't mean mental illness isn't real; it means the hormonal picture was never looked at first. That gap in care is exactly why this conversation needs to be louder.
Learn more about Rose →Oestrogen directly modulates serotonin, dopamine, and norepinephrine — the same neurotransmitter systems targeted by psychiatric medications. When oestrogen begins its erratic perimenopausal decline, mood symptoms including anxiety, low mood, and irritability are a direct neurological consequence, not evidence of a psychiatric disorder. A new onset of mood symptoms in a woman aged 40–55 warrants a hormonal evaluation before a psychiatric label is applied.
The brain is densely packed with oestrogen receptors, particularly in the amygdala, hippocampus, and prefrontal cortex — regions that govern emotional regulation, memory, and fear response. When oestrogen fluctuates, these regions are directly affected at a structural and chemical level; this is physiology, not psychology. Describing these symptoms as "just emotional" is equivalent to saying a thyroid disorder is "just about feelings."
Clinical guidelines from the British Menopause Society and others now recognise that for women whose mood symptoms are primarily hormonal in origin, HRT — not antidepressants — should be the first consideration. Multiple studies show that oestrogen therapy significantly improves mood in perimenopausal women, with some research suggesting it outperforms SSRIs for this specific population. Prescribing antidepressants without addressing the hormonal root cause is treating the smoke while ignoring the fire.
Disproportionate anger, sudden emotional outbursts, and a feeling of not recognising oneself are among the most underreported perimenopausal symptoms, and they are commonly mistaken for borderline personality disorder or other emotional dysregulation diagnoses. Oestrogen's role in regulating the amygdala — the brain's threat-detection centre — means its withdrawal can produce genuinely extreme emotional responses that have a clear biological mechanism. Women deserve to know this before they accept a personality disorder label.
SSRIs and SNRIs do offer some relief from perimenopausal mood symptoms — but this is partly because serotonin and oestrogen systems are so deeply intertwined, not because the underlying cause was a serotonin deficiency disorder. Symptom response to a drug does not retroactively confirm a psychiatric diagnosis, any more than ibuprofen reducing a fever confirms the patient had ibuprofen deficiency. This logical error keeps women on unnecessary long-term psychiatric medications.
Depersonalisation and a profound sense of identity disruption are documented perimenopausal experiences, likely linked to shifting oestrogen's effect on the default mode network in the brain. Women describing feeling like a stranger in their own lives are reporting a neurological shift, not a psychotic break or dissociative disorder. Recognising this symptom as hormonal gives women an accurate explanation and, importantly, a treatable cause.
This myth sits at the opposite end of the spectrum but is equally harmful: perimenopause is in fact a documented window of increased vulnerability for first-onset depression and anxiety disorders, particularly in women with prior mental health history. The goal is accurate diagnosis — not reflexively attributing everything to hormones any more than reflexively attributing everything to psychiatry. A thorough clinical picture includes both hormonal and psychological assessment, and good care holds both possibilities.
Memory lapses, word retrieval problems, and difficulty concentrating are among the most frightening perimenopausal symptoms precisely because they mimic the early presentation of cognitive disease. Research consistently shows that oestrogen supports neuronal function, synaptic plasticity, and glucose metabolism in the brain — and its decline produces measurable but typically reversible cognitive changes. Labelling these symptoms as psychiatric or degenerative without hormonal investigation leaves women terrified and untreated.
When a woman says "I don't think this is depression, I think this is my hormones" and a clinician interprets that as resistance or lack of insight, the system has failed her. Informed self-advocacy — especially from women who have researched the hormonal basis of their symptoms — is not denial; it is exactly the kind of patient engagement that leads to better outcomes. A clinician who cannot distinguish between a woman in denial and a woman asking the right questions is not a safe clinician for perimenopausal care.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.